Advanced Search
To read this article in full, please review your options for gaining access at the bottom of the page.

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

First page of article
Recent editorials have asked the global health community to scale up male circumcision for HIV prevention in regions with HIV epidemics following the publication of three randomized controlled clinical trials (RCCTs) in Africa (in South Africa, Uganda, and Kenya).1–5 One editorial concluded: “The proven efficacy of MC [male circumcision] and its high cost-effectiveness in the face of a persistent heterosexual HIV epidemic argues overwhelmingly for its immediate and rapid adoption.”6 This “Current Issue” review questions not the internal validity of the studies, but their external validity, an issue that has been discussed more generally in two commentaries,7,8 an editorial,9 and a systematic review of research on prevention trials10 in this journal.

To access this article, please choose from the options below

Purchase access to this article

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

 

Linked Articles

  • Joya Banerjee, Jeffrey D. Klausner, Daniel T. Halperin, Richard Wamai, Edgar J. Schoen, Stephen Moses, Brian J. Morris, Stefan A. Bailis, Francois Venter, Neil Martinson, Thomas J. Coates, Glenda Gray, Kasonde Bowa
    American Journal of Preventive Medicine, Vol. 40, Issue 3
  • Maria J. Wawer, Ronald H. Gray, David Serwadda, Godfrey Kigozi, Fred Nalugoda, Thomas C. Quinn
    American Journal of Preventive Medicine, Vol. 40, Issue 3
  • Related Articles

    Searching for related articles..

    Advertisement